<DOC>
	<DOCNO>NCT01210586</DOCNO>
	<brief_summary>This study investigate whether transdermal hormone replacement therapy ( HRT ) influence smoke cessation variable postmenopausal woman undergo short-term abstinence cigarette . Women recruit two group accord pre-enrollment medication status - currently HRT ( n = 17 ) HRT ( n = 13 ) . The HRT group prior medication replace standard 0.1 mg estradiol transdermal system 2.5 mg Cycrin daily . Following two week medication adjustment , participant continue smoke usual one week , time baseline measurement take . For remain two week , participant instruct quit smoking . They provide smoke cessation counseling monitor abstinence . Data collect five clinic visit dependent measure : Minnesota Nicotine Withdrawal Scale , Beck Depression Inventory ( BDI ) Scale , Profile Mood States , Motor Speed Tasks , Reaction Time Test . Part II identical Part I , except randomizes participant use nicotine patch .</brief_summary>
	<brief_title>Tobacco Cessation Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>4079 year old Clinical Menopause &gt; 15 cigarette per day least one year Experienced nicotine withdrawal base DSM IV Currently obtain nicotine source Abnormal vaginal bleed unstable health history stroke embolism history abnormal thyroid function significant skin disorder active psychiatric disease</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>